University of Birmingham Featured PhD Programmes
University of Liverpool Featured PhD Programmes
University of Glasgow Featured PhD Programmes
Brunel University London Featured PhD Programmes
University of Bristol Featured PhD Programmes
"breast" AND "cancer"×
10 miles

breast cancer PhD Projects, Programs & Scholarships

We have 54 breast cancer PhD Projects, Programs & Scholarships

  • "breast" AND "cancer" ×
  • clear all
Order by 
Showing 1 to 10 of 54
  Exploring mechanisms of resistance to anti-angiogenic therapy in breast cancer
  Dr C Kanthou, Prof N Brown
Applications accepted all year round
Vascular endothelial growth factor (VEGF) is a potent angiogenesis inducer and is often overexpressed in cancer. Circulating levels of VEGF as well as tumour microvessel density are of prognostic value in breast cancer.
  Investigating how platelet-derived ncRNAs are altering the genetics of breast cancer cells
  Research Group: Institute of Cancer Therapeutics
  Dr J Boyne, Prof P Loadman
Applications accepted all year round
Platelet-derived microparticles (PMPs) are capable of delivering non-coding RNAs (ncRNAs) to cells that modulate gene expression.
  Finding a therapy for triple negative breast cancer patients
  Dr K. Britt
Applications accepted all year round
Triple negative breast cancers are a poor prognosis breast cancer with limited therapeutic options as they do not express estrogen receptors, progesterone receptors or Her2.
  Ran GTPase as a potential novel therapeutic target in EMT transdifferentiation and breast cancer stem cell (BCSC) survival during metastatic development
  Research Group: Institute of Cancer Therapeutics
  Prof R Morgan, Prof M El-Tanani, Dr M Isreb, Dr M Najafzadeh
Applications accepted all year round
Breast cancer is the leading cause of cancer death in women worldwide. Accumulating evidence suggests that local disease recurrence and metastatic lesions, the major causes of patient mortality, are due to a subset of aggressive cells termed cancer stem cells (CSCs).
  Functional significance of IL-1B in breast cancer bone metastases
  Dr P Ottewell
Applications accepted all year round
Breast cancer is the most frequently diagnosed cancer and leading cause of death in women worldwide. Up to 75% of patients with advanced breast cancer develop bone metastases and patients with this condition have a median survival of around 2-3 years.
  MRC Precision Medicine DTP: Molecular pathology data science studies of breast cancer
  Dr J Figueroa, Dr A Sims, Assoc Prof N Tobin
Application Deadline: 8 April 2019
BACKGROUND. Datasets linked to molecular phenotypes are desperately needed to provide academia and industry the real-world evidence needed for discovery, validation and implementation of new biomarkers for improved cancer outcomes.
  Metabolic reprogramming and chemotherapy resistance in triple-negative breast cancer
  Dr K Brown
Applications accepted all year round
Treatment options for the triple-negative breast cancer (TNBC) subtype of breast cancer are limited to conventional chemotherapy agents.
  The Role of Molecular Regulators in Breast Cancer development using 3D models
  Dr M Ahmed, Dr A Coutts
Applications accepted all year round
Breast cancer represents a major health burden, with it being the second leading cause of cancer related death in women worldwide.
  Targeting addiction to a breast cancer metastasis survival pathway by inhibition of RAN GTPase
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Prof M El-Tanani, Dr S Betmouni
Applications accepted all year round
Metastatic cancer is a major global health burden. Each year, eleven million new cases of cancer are diagnosed worldwide, including 5 million cases in industrialized countries.
  Precision profiling the breast cancer microenvironment
  Prof V Speirs, Dr R Abu Eid
Application Deadline: 29 March 2019
The cancer microenvironment contains many different cell types, including various subsets of immune cells and cancer-associated fibroblasts, which support cancer growth.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.